resveratrol has been researched along with Nasal Polyps in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hwang, S; Kang, S; Khalmuratova, R; Kim, Y; Lee, M; Lee, Y; Park, JW; Shin, HW; Song, Y; Yu, J | 1 |
| Chang, DY; Jeon, SY; Jung, MH; Khalmuratova, R; Kim, DW; Kim, JH; Kim, SW; Lee, HK; Min, YG; Rhee, CS; Shin, EC; Shin, HW | 1 |
| Choy, YB; Huh, BK; Khalmuratova, R; Kim, SN; Lee, M; Lee, SH; Park, CG; Park, JW; Shin, HW | 1 |
3 other study(ies) available for resveratrol and Nasal Polyps
| Article | Year |
|---|---|
α-Helical cell-penetrating peptide-mediated nasal delivery of resveratrol for inhibition of epithelial-to-mesenchymal transition.
Topics: Animals; Cell-Penetrating Peptides; Chronic Disease; Epithelial-Mesenchymal Transition; Mice; Nasal Mucosa; Nasal Polyps; Resveratrol; Sinusitis | 2020 |
Resveratrol prevents development of eosinophilic rhinosinusitis with nasal polyps in a mouse model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biopsy, Needle; Blotting, Western; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Eosinophilia; Immunohistochemistry; Mice; Mice, Inbred BALB C; Nasal Polyps; Random Allocation; Real-Time Polymerase Chain Reaction; Reference Values; Resveratrol; Rhinitis; Risk Assessment; Sinusitis; Statistics, Nonparametric; Stilbenes; Treatment Outcome | 2013 |
Sinonasal Delivery of Resveratrol via Mucoadhesive Nanostructured Microparticles in a Nasal Polyp Mouse Model.
Topics: Adhesives; Administration, Intranasal; Animals; Anti-Inflammatory Agents, Non-Steroidal; Drug Carriers; Male; Mice, Inbred BALB C; Nanoparticles; Nasal Mucosa; Nasal Polyps; Resveratrol; Rhinitis; Sinusitis; Stilbenes | 2017 |